- Novel therapeutic agents and combinations for patients with relapsed or refractory solid tumors
- Planning novel biologic correlates that will enhance our scientific knowledge and aid in planning future trials
- Clinical trials of immunotherapy in combination with other agents including radiation and chemotherapy